With a market cap of $455 billion, Johnson & Johnson (JNJ) is a global healthcare conglomerate headquartered in New Brunswick ...

Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to ...

The company’s Moderate operating performance and financial health, combined with its High valuation, make the stock appear ...

Health care giant Johnson & Johnson (NYSE:JNJ) has had a good year with its shares trading near all-time highs. The company looks to keep a trend of beating analyst estimates when third-quarter ...

Shares of Johnson & Johnson were rising into record territory in early trading Tuesday, after the medicines and medical-technology giant beat quarterly earnings expectations and raised its outlook, ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. Speaking of Johnson & Johnson, Guggenheim analyst Vamil ...

The orthopedics business, which generated 10% of 2024 revenue, will be separated from J&J within two years, after its consumer health business was spun off as Kenvue in 2023 Johnson & Johnson's stock ...